Public Release: 

Prioritizing ending AIDS in children at IAS 2015

Experts from the Elizabeth Glaser Pediatric AIDS Foundation available for comments and media interviews

Elizabeth Glaser Pediatric AIDS Foundation

WHAT: The 8th IAS Conference on HIV Pathogenesis, Treatment & Prevention (IAS 2015)

Experts from the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) will give oral presentations and exhibit a variety of educational posters and abstracts related to ending AIDS in children. Key sessions include:

  • Monday, July 20, 4:30-6 p.m., Ballroom A: PMTCT Gaps and Next Steps

      o EGPAF Senior HIV Technical Advisor Lynne Mofenson Co-chairing.

  • Tuesday, July 21, 2:30-4 p.m., Ballroom B: Optimizing PMTCT Programme Implementation

      o Using the critical path for rapid expansion and optimization of a PMTCT program towards elimination of new HIV infections in children. EGPAF Presenter: Reuben Musarandega.

      o Improving early ANC attendance through community engagement and dialogue: project ACCLAIM in three African countries. EGPAF Presenter: Mary Pat Kiefer, Senior Director of Technical Leadership Development

  • Wednesday, July 22, 2:30-4 p.m., Ballroom B: Implementation and Measurement to Improve Health Systems

      o Has performance-based financing (PBF) accelerated progress towards controlling the HIV epidemic? An impact evaluation of Mozambique's HIV-focused PBF program. Presenter: Yogesh Rajkotia.

    Experts will also be available for media questions or interviews on any breaking news and research presented at the conference related to:

    • 15 million people on HIV treatment by 2015, particularly progress with women and children

    • Launch of new WHO HIV test and treat guidelines

    • Sunset of the Global Plan

    • Path forward with Sustainable Development Goals (SDGs) in relation to HIV

    • 90-90-90 targets and pediatric HIV/AIDS

    • UNAIDS goal to end AIDS by 2030

    • Prevention of mother-to-child transmission of HIV (PMTCT)

    • Pediatric HIV treatment and prevention

    Daily updates and a full list of presentations and poster sessions featuring EGPAF staff are available at

    WHEN: July 19-22, 2015

    WHERE: Vancouver Convention Centre

    1055 Canada Place

    Vancouver, Canada

    WHO: Experts from the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF), including:

    • Charles Lyons, president and CEO

    • Lynne Mofenson, M.D., senior HIV technical advisor

    • Anja Giphart, M.D., M.P.H., executive vice president, medical and scientific affairs

    • Martha Cameron, EGPAF Ambassador

    • Natella Rakhmanina, M.D., Ph.D., director of technical assistance services

    • Mary Pat Kiefer, senior director of technical leadership development

    • Appolinaire Tiam, country director, Lesotho

    WHY: The IAS Conference on HIV Pathogenesis, Treatment & Prevention is the premier gathering for those working in the field of HIV research, treatment and program implementation, as well as policy makers, people living with HIV, and other individuals committed to ending the pandemic. It is a chance to assess where we are, evaluate recent scientific developments and lessons learned, and collectively chart a course forward.

    EGPAF is the global leader in the effort to end AIDS in children. As the global HIV/AIDS community gathers for IAS 2015, EGPAF urges conference delegates, policy makers, non-governmental organizations, and ministries of health around the world to prioritize children who are living with and affected by HIV/AIDS in current and future efforts.


    CONTACT: To schedule an interview in-person or via phone with the experts listed above or any of EGPAF's conference presenters, please contact Johanna Harvey at or (336)-202-0324.

    About the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF):

    EGPAF is the global leader in the fight against pediatric HIV/ AIDS, and has reached 22 million women with services to prevent transmission of HIV to their babies. It currently supports more than 7,000 health facilities and works in 15 countries to implement prevention, care, and treatment services; to further advance innovative research; and to execute global advocacy activities that bring dramatic change to the lives of millions of women, children, and families worldwide. For more information, visit

  • Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.